I posted this as well on the Raging Bull board: Thank goodness Pluvia (someone in Las Vegas) has caught a fundamental error that has fooled Roche, NIH, and, well, just about anybody else in the HIV scientific community (I am not a member of that community, but a close relative is). Pretty amazing, isn't it? Pluvia, as I said before, I hope you lose your shirt--there are many reasons why this stock may go down in the short run, but your "report" won't be one of them.
There are a host of interesting questions surrounding this company and it's product pipeline--why is the Phase III trail late in starting, when will the phase I trail results for t-1249 be released and what will they show, how efficacious will Trimeris's fusion technology be against other viruses and when will trails for these medications begin? The list goes on.
It used to be the case that the Yahoo board was the best for informed discussion, but no longer, sadly.
Mark. |
